Mustang Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Selling, General & Admin	9.69	12.21	11.02	9.51	9.57	6.76	11.41	2.82
Research & Development	41.04	63.95	55.71	47.3	36.32	24.46	20.38	8.55
Other Operating Expenses	-1.47	0	0	0	0	0	0	0
Operating Expenses	49.26	76.16	66.72	56.81	45.89	31.22	31.79	11.36
Operating Income	-49.26	-76.16	-66.72	-56.81	-45.89	-31.22	-31.79	-11.36
Interest Expense / Income	4.11	3.36	0.02	3.92	1.77	0.01	0.01	1.15
Other Expense / Income	-1.77	-1.99	-0.37	-0.71	-1.26	-0.57	-0.51	0.14
Pretax Income	-51.6	-77.53	-66.37	-60.02	-46.39	-30.66	-31.29	-12.65
Net Income	-51.6	-77.53	-66.37	-60.02	-46.39	-30.66	-31.29	-12.65
Shares Outstanding (Basic)	9	8	6	4	2	2	2	1
Shares Outstanding (Diluted)	9	8	6	4	2	2	2	1
Shares Change	11.97%	31.16%	67.12%	45.83%	33.81%	6.72%	129.02%	-
EPS (Basic)	-6.00	-10.09	-11.40	-17.10	-19.35	-17.10	-18.60	-17.25
EPS (Diluted)	-6.00	-10.09	-11.40	-17.10	-19.35	-17.10	-18.60	-17.25
Free Cash Flow	-43.54	-67.65	-57.65	-39.24	-35.93	-26.11	-13.37	-4.13
Free Cash Flow Per Share	-5.06	-8.80	-9.84	-11.19	-14.94	-14.54	-7.94	-5.62
EBITDA	-45.27	-71.14	-64.05	-54.31	-43.25	-30.02	-31.28	-11.51
Depreciation & Amortization	2.23	3.03	2.31	1.79	1.37	0.63	0	0
EBIT	-47.49	-74.17	-66.36	-56.1	-44.62	-30.65	-31.28	-11.51

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).